Vanishing bile duct syndrome (VBDS) is a disorder presented with jaundice and prolonged cholestasis due to intrahepatic cholestasis with the paucity of interlobular bile ducts. Liver involvement of Hodgkin's lymphoma (HL) is well-known however VBDS is an extremely rare presentation of HL. Lack of wellestablished pathogenetic mechanism and rarity of disorder may cause diagnostic confusion. We reported a VBDS case related to Hodgkin's lymphoma, presented with generalized jaundice. 
Introduction
Vanishing bile duct syndrome (VBDS) defines different pathological conditions that occur with infection, ischemia, drug side effects, autoimmune diseases, allograft rejection and malignancy related humoral factors (1) . Due to intrahepatic bile duct injury and ductopenia, various clinical tables such as cholestasis, biliary cirrhosis or liver failure can occur. Although the incidence of VBDS associated with Hodgkin's lymphoma (HL) is not high, the paraneoplastic effect of malignancy mediated cytokines is highly responsible for its mechanism. In this article, a VBDS case with HL diagnosis is presented. 
Case Presentation

Discussion
VBDS is characterized by a group of diseases that result in the disappearance of bile ducts with progressive damage resulting in cholestasis (2) . There are several factors may be responsible showed that thosepatients are commonly presented with jaundice, pruritis and weight loss similar to our case (9) .
Because the HL related VBDS mechanism cannot be clearly defined, the treatment is complex and controversial. Depending on the underlying etiology, assessment of risk of drug use is among the options for UDCA, immunosuppressive agents, and chemoradiotherapy. It has been shown that treatment with an anion modulating apheresis may be effective in resistant cases (10) . Liver transplantation may be necessary in cases involving severe complications of liver decompensation (11) .
Prognosis of VBDS depends on etiology as well as the severity of the damage. Malignancy-associated VBDS has a poor prognosis compared to other causes, but the VDBS that occurred as a result of medical treatment of HL is usually reversible. In a statistical analysis of the reported cases in the literature, 30% of patients receiving standard therapy for HL have been shown to have positive results on lymphoma progression and liver function (12) . Therefore, HL therapy appears to be the most important factor in increasing survival.
Early aggressive treatment, which is started by determining the relationship between the results of appropriate laboratory and radiological examinations, is crucial for achieving a successful outcome by regenerating the bile duct epithelium.
Bilirubin levels can be used as a more reliable laboratory marker in the evaluation of response to treatment, when compared to ALP (13) . In conclusion, the differential diagnosis of lymphoma and other malignancies must be done in VBDS patients who are thought to be unrelated to clinical and laboratory parameters. 
